Ossur Hf : Share options granted
Announcement from Össur hf. No.20/2012
Reykjavik, 23 May 2012
Today, Össur hf. has granted 500,000 share options to Dr. Thorvaldur Ingvarsson
who will become Executive Vice President of R&D at Össur as of 30 June 2012. The
exercise price is DKK 8.59, i.e. the Company's average share price on NASDAQ OMX
Copenhagen 20 trading days prior to the grant date. First exercise date is 23
May 2015. Dr. Ingvarsson holds no shares in Össur.
The share options are granted in accordance with the Company's share option
scheme implemented on 24 April 2012. Further details on the share option scheme,
including the key terms and conditions, can be found in the Company's
announcement No. 16/2012 published on 24 April 2012.
Össur press releases by e-mail
If you wish to receive Össur press releases by e-mail please register at the
following web-site: http://www.ossur.com/investormailings.
About Össur
Össur (NASDAQ OMX: OSSR) is a global leader in non-invasive orthopaedics that
help people live a life without limitations. Its business is focused on
improving people's mobility through the delivery of innovative technologies
within the fields of braces, supports, prosthetic limbs and compression therapy,
including the Flex-Foot Cheetah carbon fiber running prostheses used by "The
Blade Runner," renowned double-amputee sprinter Oscar Pistorius. A recognized
"Technology Pioneer", Össur invests significantly in research and product
development; its award-winning designs ensuring a consistently strong position
in the market. Successful patient and clinical outcomes are further empowered
via Össur's educational programs and business solutions. Headquartered in
Iceland, Össur has major operations in the Americas, Europe and Asia, with
additional distributors worldwide. www.ossur.com